Skip to content
Facebook-f Twitter
KAOHOON INTERNATIONAL
  • Thailand
  • Asia
  • USA
  • World
  • |
  • Markets
  • Economics
  • Wealth
  • Technology
  • Politics
  • Opinion
  • Sustainability
Trending News
May 14, 2026
Ichitan Reports Robust 1Q26 Performance with 17% Profit Surge as Non-Tea Segment Skyrockets
May 14, 2026
PLANB Kicks Off 1Q26 with Strong Top and Bottom Line Performance
May 14, 2026
SISB Books THB215 Million of Net Profit in 1Q26 amid Rising Tuition Yields
May 14, 2026
BEM Sees Flat Growth in 1Q26 as Resilient Commuter Demand Offsets Slump in Commercial Business
Home
/
PR9
/
Page 3
Posted 19/01/2026

PR9 Jumps 5%, Targeting Double-Digit Medical Service Revenue Growth in 2026

At 03:58 P.M. (GMT+7), the share price of Praram 9 Hospital Public Company Limited...

Posted 12/01/2026

Thai Hospital Stocks Slump amid Concerns over Potential Changes to Health Insurance Policy

On Monday at 11:02 AM (Bangkok time), the share price of Bumrungrad Hospital Public...

Posted 23/12/2025

PR9 Projects Double-Digit Revenue Increase in 2025, Eyes Bed Capacity Expansion

Miss Kamaporn Tumpipit, Chief Financial Officer and Executive (The highest responsible person in Accounting...

Posted 15/12/2025

Tisco Sees Positive Outlook for International-Focused Thai Hospitals following Kuwait Payment

Recent developments in the Thai healthcare sector indicate a positive outlook for 2026, following...

Posted 08/12/2025

Kiatnakin Eyes BDMS and PR9 as Thai Hospital Sector Set to Normalize Growth in 2026

The Thai healthcare sector, which has seen its stocks drop by 25% year-to-date and...

Posted 20/11/2025

Praram 9 Hospital Sets Sights on Double-Digit Growth amid Optimism on Robust Patient Volume

Praram 9 Hospital Public Company Limited (SET: PR9) expects significant growth in fourth-quarter 2025...

Posts navigation

Prev Prev 1 2 3 4 … 6 Next Next

TOP NEWS OF THE WEEK

© KAOHOON. All Rights Reserved.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, it is assumed that you accept our Privacy policy.Accept and Close